Bristol-Myers Squibb (BMY) Settles Clean-Air Case -Bloomberg
Bloomberg is reporting that Bristol-Myers Squibb (NYSE: BMY) has settle its clean-air case and will spend $3.7 million to reduce the amount of ozone at its plants. Similarly, Bristol-Myers will pay $127,000 in civil penalties.
Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and other health care related products worldwide.
Related Categories
Corporate NewsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
